ACMT Highlights Tox in Ten Episode 74 - Receptor Agonists for Treatment of Alcohol Use Disorder

Gillian Beauchamp, MD, is Vice Chair for Education and Community Engagement in the Lehigh Valley Health Network Department of Emergency and Hospital Medicine & Division of Medical Toxicology. She is an Associate Professor at USF Morsani College of Medicine, and Adjunct Clinical Associate Professor at Jefferson University. She is board certified in Emergency Medicine, Medical Toxicology and Addiction Medicine. She is an Editorial board member for Toxicology Communications and a Reviews Section Editor and Editorial board member for the Journal of Medical Toxicology; and is co-host for the Tox in Ten: ACMT Highlights podcast.

Dr. Stephanie Weiss is the Staff Research Physician serving the National Institute on Drug Abuse’s Intramural Research Program. After earning a Ph.D. in pharmaceutical chemistry, Dr. Weiss received her medical degree in 2011. She is board certified in addiction medicine and medical toxicology and participated in the Boston University Research in Addiction Medicine Scholars Program prior to joining NIDA. Dr. Weiss is responsible for providing optimal, safe, and ethical care to study participants and clinical support toward the NIDA IRP mission of conducting inpatient and outpatient proof-of-concept human laboratory therapeutic and imaging studies for addictive disorders. Her research interests include GLP-1RAs, medication misuse, and improving interpretation of urine drug testing.